Investment
Features
FeesSafety
Academy
More
Pluang+

Compare CF Industries Holdings, Inc. (CF) vs Johnson & Johnson (JNJ) Price & Performance

CF Industries Holdings, Inc.Trade
Johnson & JohnsonTrade

Price performance (Past 24H)

Key statistics

CF Industries Holdings, Inc. vs Johnson & Johnson — how do they compare? CF Industries Holdings, Inc. trades at $117.8 (market cap $18.38B), while Johnson & Johnson trades at $259.44 (market cap $630.94B). The key difference: Johnson & Johnson is far larger — about 34.3× CF Industries Holdings, Inc.'s market cap, and Johnson & Johnson pays the higher dividend (2.05%). Which is the better fit depends on your goals.

CFJNJ
Market Cap
$18.38B$630.94B
Sector
Basic MaterialsHealth
52-Week High
$137.55$267.24
52-Week Low
$76.08$172.78
Enterprise Value
$19.52B$659.21B
Dividend Yield
1.98%2.05%
Volume
6,156,228

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

CF Industries Holdings, Inc.

CF Industries Holdings (CF) trades at $114.35, down 2.04% today, reflecting a bearish technical trend with support at $112 and resistance at $116. The company reported mixed Q2 2026 earnings, missing EPS estimates at $4.73 versus $5.63 expected, but revenue grew 17.6% year-over-year on strong nitrogen pricing. Fundamentals remain solid with a P/E of 8.48 and net income margin of 27.12%, while cash flow improved to $368 million in 2025. Recent news highlights institutional buying and nitrogen market tightness supporting mid-cycle earnings.

Outlook is cautiously optimistic; CF benefits from robust nitrogen demand and pricing, with analyst consensus target at $119.60 implying upside. Risks include volume volatility from plant outages and debt levels, but high ROE (39.19%) and dividend payments signal financial health. Investors may find value at current levels if operational execution aligns with favorable industry conditions.

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $259.24, up 0.88% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $282.33. Recent earnings beat expectations in Q1 and Q2 2026, with Q3 results pending. The company maintains strong profitability, including a 67.91% gross margin and 21.48% net income margin, supported by consistent dividend payments, including a recent $1.34 per share payout.

JNJ offers stability with a 64-year dividend growth streak and robust fundamentals, but risks include rising debt-to-asset ratios (24.06% in 2025) and sector volatility. Upside potential hinges on execution of growth initiatives and healthcare market dynamics, with analysts favoring a buy rating (52.5% consensus).

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About CF Industries Holdings, Inc.

CF Industries is a leading producer and distributor of nitrogen fertilizers. The company operates seven nitrogen facilities in North America and holds joint venture interests in further production capacity in the United Kingdom and Trinidad and Tobago. CF makes nitrogen primarily using low-cost U.S. natural gas as its feedstock, making CF one of the lowest-cost nitrogen producers globally.

Read more on CF

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

Read more on JNJ